West Pharmaceutical Services, Inc.

NYSE:WST

Medical - Instruments & Supplies

Healthcare
$404.02 +1.56%

+$5.04 today

Market cap
$28.14B
Beta
1.18
P/E (TTM)
43.6
EPS (TTM)
$7.54
Dividend yield
0.26%
52W Low $206.80High $336.82

Volume 0.59M

Average 0.85M

WST Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

West Pharmaceutical Services, Inc.NYSE: WST

Net Debt · Q2 FY2026 · quarter ended Jun 2026

Net debt remains negative

Q2 FY2026 net debt was -$123.7M, compared with -$206.4M a year earlier.

Context

  • Net debt amounted to 3.0% of total assets at the end of Q2 FY2026, down 2.2 pp from a year earlier.
  • Net debt grew in size in 1 of the last 3 fiscal years.

What to watch

Whether net debt keeps rising in the next quarterly balance sheet after a +40.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$123.7M+39.7% QoQ
Last fiscal yearDec 2025
-$374.6M-108.9% YoY
Year agoJun 2025
-$206.4M+40.1% since
Net Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+40.1%——
1 year-108.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Debt history

USD · from the balance sheet

Latest · FY2025
(374.6M) USD
Year-over-year change
-108.9%

Net Debt vs competitors

How WST compares with its peers on the latest reported figures

  • Peers report in different currencies, so net debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +40.1% is the 2nd highest of 5, against a peer median of +20.3%.
  • Net debt amounts to 3.0% of total assets for WST, versus a peer median of 19.0%.
WST Competitors
Net Debt for WST and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ATRAptarGroup, Inc.Jun 2026$1.24B USD+26.9%+1.5%24.1%
ICUIICU Medical, Inc.Jun 2026$973.27M USD-10.7%-10.8%24.5%
STVNStevanato Group S.p.A.Jun 2026€364.35M EUR+13.6%—13.9%
BLFSBioLife Solutions, Inc.Mar 2026-$7.97M USD+80.1%—2.0%
WSTWest Pharmaceutical Services, Inc.Jun 2026-$123.7M USD+40.1%—3.0%
Peer median (excluding WST) —+20.3%-4.6%19.0%

Competitors are the stored peer set for WST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents762.6M894.3M853.9M484.6M791.3M
Short-term Investments00000
Net Receivables489M507.4M512M552.5M574.4M
Inventory378.4M414.8M434.7M377M443.9M
Other Current Assets112M103M135.8M124M168.6M
Total Current Assets1.74B1.92B1.94B1.54B1.98B
Property, Plant & Equipment (Net)1.13B1.26B1.51B1.69B1.84B
Goodwill109.9M107.3M108.5M106.1M110M
Intangible Assets23M18.4M15.1M10.8M7.7M
Long-term Investments207.7M204.9M210M202.1M212.3M
Tax Assets48.5M65.6M25.7M26M38.4M
Other Non-current Assets55.9M38.4M21.3M74.3M80.1M
Total Non-current Assets1.57B1.7B1.89B2.11B2.29B
Total Assets3.31B3.62B3.83B3.64B4.27B
Account Payables232.2M215.4M242.4M239.3M253.7M
Short-term Debt44.2M2.2M134M18.8M22.7M
Tax Payables39.3M38.5M31M50.3M0
Deferred Revenue48.7M57.3M41.7M49.6M0
Other Current Liabilities45.1M54M54.2M100.5M214.5M
Total Current Liabilities594.1M519M671.8M550.4M654.9M
Long-term Debt208.8M206.7M72.8M202.6M298.4M
Deferred Tax Liabilities4.9M14.3M12.7M20.5M23M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities107.6M98.9M106.7M103.7M22.1M
Total Non-current Liabilities384.3M412.9M276.7M410.7M439.1M
Total Liabilities978.4M931.9M948.5M961.1M1.09B
Common Stock18.8M18.8M18.8M18.8M18.8M
Retained Earnings2.46B2.99B3.52B3.96B4.37B
Accumulated OCI(159.6M)(183M)(143.8M)(258.1M)(105.5M)
Other Stockholders Equity0000(1)
Minority Interest00000
Total Equity2.34B2.68B2.88B2.68B3.18B
Total Debt325.3M317.9M309M305.3M416.7M
Net Debt(437.3M)(576.4M)(544.9M)(179.3M)(374.6M)

West Pharmaceutical Services, Inc.

NYSE:WST

Intrinsic Alpha fair value

Locked

Current Price

$404.02

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.